Biotoxtech Co., Ltd. (KOSDAQ: 086040)

Biotoxtech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18,923	27,479	12,700	18,592	2,747	5,377
Short-Term Investments	12,500	13,559	17,059	9,559	4,559	4,559
Trading Asset Securities	-	-	1,012	-	13,865	-
Cash & Short-Term Investments	31,423	41,038	30,771	28,151	21,171	9,936
Cash Growth	42.57%	33.37%	9.31%	32.97%	113.08%	-9.41%
Accounts Receivable	6,329	5,355	7,352	5,813	3,802	4,752
Other Receivables	480.41	445.37	158.2	1,055	664.07	650.57
Receivables	8,790	8,392	10,261	8,631	4,949	6,102
Inventory	10,567	11,915	4,454	674.04	835.62	708.31
Prepaid Expenses	137.76	113.14	257.66	202.19	33.53	32.54
Other Current Assets	3,018	3,233	3,387	88.11	188.74	398.5
Total Current Assets	53,936	64,692	49,130	37,746	27,178	17,178
Property, Plant & Equipment	57,480	58,181	58,066	25,409	22,055	21,965
Long-Term Investments	11,361	10,689	10,130	18,373	11,119	18,713
Other Intangible Assets	1,604	1,596	1,483	1,479	1,203	48.34
Long-Term Accounts Receivable	-	-	-	-	-0	-0
Long-Term Deferred Tax Assets	5,479	5,344	1,072	565.72	190.43	1,090
Long-Term Deferred Charges	-	-	-	58.46	116.92	175.38
Other Long-Term Assets	1,896	1,865	819.42	2,110	1,793	1,006
Total Assets	136,693	147,036	125,700	90,741	63,655	60,176
Accounts Payable	844.08	541.98	783.54	815.54	819.28	737.86
Accrued Expenses	205.63	80.5	56	28.1	35.09	55.11
Short-Term Debt	37,747	41,229	27,853	23,843	9,406	10,676
Current Portion of Long-Term Debt	1,250	-	1,000	1,000	4,750	750
Current Portion of Leases	200.24	171.03	150.43	199.46	178.79	70.38
Current Income Taxes Payable	-	-	250.29	48.79	-	-
Current Unearned Revenue	1	-	-	-	-	11.43
Other Current Liabilities	31,822	33,096	29,435	19,841	10,528	9,881
Total Current Liabilities	72,070	75,119	59,528	45,777	25,718	22,182
Long-Term Debt	18,750	20,000	20,000	1,909	2,825	5,750
Long-Term Leases	138.99	191.59	136.81	97.13	101.52	187.58
Other Long-Term Liabilities	46.53	171.68	161.1	38.12	5.2	280
Total Liabilities	94,282	98,801	81,334	48,892	29,373	28,981
Common Stock	7,979	7,979	7,334	7,334	7,313	7,294
Additional Paid-In Capital	34,362	34,125	21,598	21,058	19,973	19,632
Retained Earnings	3,441	6,740	12,162	9,354	2,428	84.65
Treasury Stock	-165.68	-165.68	-165.68	-165.68	-165.68	-165.68
Comprensive Income & Other	2,876	3,032	3,307	3,563	3,978	3,348
Total Common Equity	48,491	51,710	44,235	41,144	33,526	30,192
Minority Interest	-6,080	-3,475	131.97	705.69	755.92	1,003
Shareholders' Equity	42,411	48,235	44,367	41,849	34,282	31,195
Total Liabilities & Equity	136,693	147,036	125,700	90,741	63,655	60,176
Total Debt	58,086	61,591	49,140	27,049	17,262	17,434
Net Cash (Debt)	-26,663	-20,553	-18,369	1,102	3,910	-7,498
Net Cash Growth	-	-	-	-71.82%	-	-
Net Cash Per Share	-1672.93	-1332.10	-1255.03	71.58	267.78	-515.41
Filing Date Shares Outstanding	15.93	15.93	14.64	14.64	14.59	14.56
Total Common Shares Outstanding	15.93	15.93	14.64	14.64	14.59	14.56
Working Capital	-18,134	-10,426	-10,398	-8,031	1,460	-5,005
Book Value Per Share	3044.49	3246.60	3022.26	2811.05	2297.16	2074.08
Tangible Book Value	46,887	50,115	42,752	39,665	32,323	30,144
Tangible Book Value Per Share	2943.77	3146.42	2920.96	2710.03	2214.75	2070.76
Land	6,668	6,668	6,668	6,650	4,308	3,845
Buildings	51,463	51,458	51,213	22,710	22,451	22,412
Machinery	13,510	13,203	10,913	4,666	6,257	6,273
Construction In Progress	-	1.78	131.6	1,654	278.2	-

Source: S&P Capital IQ. Standard template. Financial Sources.